Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24780364 | 0.81 | TSHR (0.39) | ALDH1A1TDP1 | |
| SCHEMBL24780370 | 0.77 | NPSR1 (0.31) | ALDH1A1 | |
| SCHEMBL24780994 | 0.77 | TSHR (0.35) | ALDH1A1HSD17B10 | |
| SCHEMBL24780355 | 0.74 | TSHR (0.42) | ALDH1A1 | |
| SCHEMBL25473438 | 0.74 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL24780369 | 0.74 | ALDH1A1 (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL5173389 | 0.72 | ALDH1A1 (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL7175558 | 0.71 | CYP2C19 (0.33) | ALDH1A1 | |
| SCHEMBL4778954 | 0.70 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL3661507 | 0.69 | TSHR (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023083295-A1 | ESTER DERIVATIVES OF N4-HYDROXYCYTIDINE AND USE THEREOF | SUZHOU SPRING-SEA BIO-PHARMACEUTICALS CO., LTD. (CN) | 2023-05-19 | — | — | WO | disclosed |
| WO-2022262845-A1 | ESTER DERIVATIVES OF N4-HYDROXYCYTIDINE AND USE THEREOF | SUZHOU SPRING-SEA BIO-PHARMACEUTICALS CO., LTD. (CN) | 2022-12-22 | — | — | WO | disclosed |